Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
British Journal of Cancer|November 27, 2008
The spliceosome as target for anticancer treatmentR J van Alphen, E A C Wiemer, H Burger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)R H Mathijssen, R J van Alphen, J Verweij, et al.Anti-Cancer Drugs|April 9, 1999
Sparse-data set analysis for irinotecan and SN-38 pharmacokinetics in cancer patients co-treated with cisplatinR H Mathijssen, R J van Alphen, M J de Jonge, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Irinotecan (CPT-11) metabolism and disposition in cancer patientsA Sparreboom, M J de Jonge, P de Bruijn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Pharmacokinetic, metabolic, and pharmacodynamic profiles in a dose-escalating study of irinotecan and cisplatinM J de Jonge, J Verweij, P de Bruijn, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2017
Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer GroupJ J M Kwakman, L H J Simkens, J M van Rooijen, et al.Pageof 1